These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 38578312)
41. Increased expression of Fas receptor and Fas ligand in the culture of the peripheral blood mononuclear cells stimulated with Borrelia burgdorferi sensu lato. Grygorczuk S; Osada J; Moniuszko A; Świerzbińska R; Kondrusik M; Zajkowska J; Dunaj J; Dąbrowska M; Pancewicz S Ticks Tick Borne Dis; 2015 Mar; 6(2):189-97. PubMed ID: 25541498 [TBL] [Abstract][Full Text] [Related]
48. Evaluation of Borrelia burgdorferi BbHtrA Protease as a Vaccine Candidate for Lyme Borreliosis in Mice. Ullmann AJ; Russell TM; Dolan MC; Williams M; Hojgaard A; Weiner ZP; Johnson BJ PLoS One; 2015; 10(6):e0128868. PubMed ID: 26076465 [TBL] [Abstract][Full Text] [Related]
49. Linear scleroderma 'en coup de sabre' associated with facial atrophy in a patient seropositive for Borrelia burgdorferi: a true case of molecular mimicry? Salpietro DC; Merlino MV; Bruglia S; Guarneri F; Vaccaro M Pediatr Allergy Immunol; 2004 Dec; 15(6):570-2. PubMed ID: 15610374 [No Abstract] [Full Text] [Related]
50. Lyme borreliosis: insights into tick-/host-borrelia relations. Grubhoffer L; Golovchenko M; Vancová M; Zacharovová-Slavícková K; Rudenko N; Oliver JH Folia Parasitol (Praha); 2005 Nov; 52(4):279-94. PubMed ID: 16405291 [TBL] [Abstract][Full Text] [Related]
52. Insights into the biology of Borrelia burgdorferi gained through the application of molecular genetics. Groshong AM; Blevins JS Adv Appl Microbiol; 2014; 86():41-143. PubMed ID: 24377854 [TBL] [Abstract][Full Text] [Related]
53. Autoimmunity in Lyme disease: molecular cloning of antigens recognized by antibodies in the cerebrospinal fluid. Schluesener HJ; Martin R; Sticht-Groh V Autoimmunity; 1989; 2(4):323-30. PubMed ID: 2491615 [TBL] [Abstract][Full Text] [Related]
54. Molecular characterization of the OspA(161-175) T cell epitope associated with treatment-resistant Lyme arthritis: differences among the three pathogenic species of Borrelia burgdorferi sensu lato. Drouin EE; Glickstein LJ; Steere AC J Autoimmun; 2004 Nov; 23(3):281-92. PubMed ID: 15501399 [TBL] [Abstract][Full Text] [Related]
55. Structure-Based Design of Diagnostics and Vaccines for Lyme Disease. Thomas S Methods Mol Biol; 2022; 2410():411-422. PubMed ID: 34914060 [TBL] [Abstract][Full Text] [Related]
56. Genotypic variation and mixtures of Lyme Borrelia in Ixodes ticks from North America and Europe. Crowder CD; Matthews HE; Schutzer S; Rounds MA; Luft BJ; Nolte O; Campbell SR; Phillipson CA; Li F; Sampath R; Ecker DJ; Eshoo MW PLoS One; 2010 May; 5(5):e10650. PubMed ID: 20498837 [TBL] [Abstract][Full Text] [Related]
57. Outer surface proteins of Borrelia: peerless immune evasion tools. Pulzova L; Bhide M Curr Protein Pept Sci; 2014 Feb; 15(1):75-88. PubMed ID: 24555888 [TBL] [Abstract][Full Text] [Related]
58. Cimetidine as a novel adjunctive treatment for early stage Lyme disease. Shemenski J Med Hypotheses; 2019 Jul; 128():94-100. PubMed ID: 27107653 [TBL] [Abstract][Full Text] [Related]
60. Predictive value of Borrelia burgdorferi IgG antibody levels in patients referred to a tertiary Lyme centre. Zwerink M; Zomer TP; van Kooten B; Blaauw G; van Bemmel T; van Hees BC; Vermeeren YM; Landman GW Ticks Tick Borne Dis; 2018 Mar; 9(3):594-597. PubMed ID: 29422448 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]